Brief: Neuraxis Terminates License Agreement With Masimo
03/07/2025 18:34
July 3 (Reuters) - Neuraxis Inc NRXS.A: NEURAXIS INC - TERMINATES LICENSE AGREEMENT WITH MASIMO - SEC FILING NEURAXIS INC - TO PAY MASIMO $200,000 IN TWO INSTALLMENTS - SEC FILING Source text: [ID:n0001641172-25-017723] Further company coverage: NRXS.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuraxis
See all newsBrief: Neuraxis Inc Expects Net Sales Of About $1.6 Million For Three Months Ended March 31, 2026
Brief: Neuraxis Reports Strong Fourth Quarter And Full Year 2025 Financial Results
Brief: Neuraxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access To More Patients With Functional Abdominal Pain
Brief: Neuraxis Wins First FDA Nod for FD Pain Treatment
Brief: Neuraxis Terminates License Agreement With Masimo